|
Name |
N-hydroxy-N'-[2-(trifluoromethyl)phenyl]pyridine-3-carboximidamide
|
Molecular Formula | C13H10F3N3O | |
IUPAC Name* |
N-hydroxy-N'-[2-(trifluoromethyl)phenyl]pyridine-3-carboximidamide
|
|
SMILES |
C1=CC=C(C(=C1)C(F)(F)F)N=C(C2=CN=CC=C2)NO
|
|
InChI |
InChI=1S/C13H10F3N3O/c14-13(15,16)10-5-1-2-6-11(10)18-12(19-20)9-4-3-7-17-8-9/h1-8,20H,(H,18,19)
|
|
InChIKey |
QBQQPVCKEDSAHQ-UHFFFAOYSA-N
|
|
Synonyms |
Maybridge3_005175; DTXSID601017171; HMS1445L05; ZINC4335895; N-hydroxy-N'-[2-(trifluoromethyl)phenyl]pyridine-3-carboximidamide; IDI1_016562; N-(2-Trifluoromethylphenyl)pyridine-3-carboxamide oxime; Pyridine-3-carboxamide, oxime, N-(2-trifluoromethylphenyl)-; N'-Hydroxy-N-[2-(trifluoromethyl)phenyl]-3-pyridinecarboximidamide #; 288246-53-7
|
|
CAS | 288246-53-7 | |
PubChem CID | 550559 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 281.23 | ALogp: | 2.4 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 20 | QED Weighted: | 0.498 |
Caco-2 Permeability: | -4.382 | MDCK Permeability: | 0.00002470 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.011 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.427 | Plasma Protein Binding (PPB): | 83.96% |
Volume Distribution (VD): | 3.424 | Fu: | 17.43% |
CYP1A2-inhibitor: | 0.786 | CYP1A2-substrate: | 0.44 |
CYP2C19-inhibitor: | 0.8 | CYP2C19-substrate: | 0.119 |
CYP2C9-inhibitor: | 0.353 | CYP2C9-substrate: | 0.883 |
CYP2D6-inhibitor: | 0.34 | CYP2D6-substrate: | 0.528 |
CYP3A4-inhibitor: | 0.718 | CYP3A4-substrate: | 0.233 |
Clearance (CL): | 0.908 | Half-life (T1/2): | 0.492 |
hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.464 |
Drug-inuced Liver Injury (DILI): | 0.974 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0.778 | Maximum Recommended Daily Dose: | 0.805 |
Skin Sensitization: | 0.329 | Carcinogencity: | 0.123 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.468 |
Respiratory Toxicity: | 0.97 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000663 | 0.301 | D0E3BH | 0.402 | ||||
ENC000048 | 0.286 | D0B2WJ | 0.370 | ||||
ENC001375 | 0.276 | D00HGB | 0.354 | ||||
ENC000093 | 0.276 | D0Q9JT | 0.333 | ||||
ENC000295 | 0.275 | D0TR5X | 0.311 | ||||
ENC000326 | 0.268 | D06NVJ | 0.306 | ||||
ENC000013 | 0.266 | D09YVX | 0.303 | ||||
ENC000047 | 0.265 | D0Z9VB | 0.281 | ||||
ENC000321 | 0.265 | D03YGR | 0.275 | ||||
ENC001449 | 0.261 | D08ROP | 0.271 |